Fabrinet filings document the company’s operating results, financial condition, governance matters and shareholder actions as a Cayman Islands registrant listed under the FN symbol. Its Form 8-K reports furnish quarterly and annual financial results press releases and also record material governance events, including board appointments, director retirements and executive incentive compensation arrangements.
Proxy materials and annual meeting reports disclose board elections, auditor ratification, advisory executive compensation votes, ordinary-share voting results and meeting procedures. Together, these filings provide formal records of Fabrinet’s manufacturing-services business disclosures, capital and shareholder structure, compensation oversight and public-company governance.
Fabrinet director F. Thomas Kelly reported multiple transactions in the company’s ordinary shares. On February 25, 2026, he sold a total of 1,850 shares in open-market transactions at weighted average prices around $622–$626 per share, in several tranches.
On February 26, 2026, he disposed of an additional 150 shares as a bona fide gift with no sale proceeds. Following these transactions, his directly held stake was reported as 17,181 ordinary shares.
FN filed a Form 144 reporting a proposed sale of common stock through Morgan Stanley Smith Barney LLC as broker. The notice lists broker details and an intended transaction on 02/25/2026.
The filing also discloses that Thomas F. Kelly sold 2,200 common shares on 12/04/2025 for $1,021,111.30.
Morgan Stanley Smith Barney LLC filed a Form 144 reporting 500 shares of common stock to be sold. The filing lists 500 shares associated with "Shares Purchased through Employee Stock Purchase Plan" and a transaction date of 02/09/2026. The security is listed as Common on the NYSE.
Fabrinet reported strong growth for the quarter ended December 26, 2025. Revenues rose to $1,132.9M from $833.6M a year earlier, while net income increased to $112.6M from $86.6M. Basic earnings per share grew to $3.14 from $2.40.
For the first six months of fiscal 2026, revenue reached $2,111.0M versus $1,637.8M, and net income rose to $208.6M from $164.0M. Growth was driven largely by optical communications and non‑optical markets such as automotive and high‑performance computing across North America, Asia-Pacific and Europe.
The company ended the quarter with cash and cash equivalents of $319.9M and short‑term investments of $640.9M, and total shareholders’ equity of $2,184.8M. Operating cash flow was $148.8M for the six months, as Fabrinet increased inventories and invested $96.9M in property, plant and equipment to expand capacity.
Fabrinet furnished a current report to share that it has released financial results for its fiscal quarter ended December 26, 2025. The company distributed these results in a press release dated February 2, 2026, which is included as Exhibit 99.1 to the report.
The report classifies this disclosure under results of operations and financial condition, and notes that the press release and related information are being furnished rather than filed under securities laws, which affects how they may be used in other regulatory filings.
T. Rowe Price Associates, Inc. reports beneficial ownership of 4,041,675 shares of Fabrinet common stock, representing 11.3% of the class as of 12/31/2025. The firm has sole voting power over 3,842,803 shares and sole dispositive power over 4,041,666 shares, with no shared voting or dispositive power.
The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Fabrinet, according to the certification. T. Rowe Price Associates also states that this filing should not be construed as an admission that it is the beneficial owner of these securities, and such beneficial ownership is expressly denied.
Fabrinet director Frank H. Levinson reported an equity award in the company’s ordinary shares. On 12/11/2025, he received 417 restricted share units as part of his compensation for serving on the Board of Directors. Each restricted share unit represents a contingent right to receive one ordinary share of Fabrinet stock at no purchase price.
The units will vest on January 1, 2027, provided he continues to serve on the board through that date. Following this grant, Levinson beneficially owns 7,021 ordinary shares on a direct basis. This is a routine Form 4 insider report documenting director equity compensation rather than an open-market share purchase.
Fabrinet director reports new restricted share unit grant
A Fabrinet director reported receiving 417 restricted share units on December 11, 2025 as part of compensation for serving on the company’s Board of Directors. Each unit represents a contingent right to receive one Fabrinet ordinary share at a price of $0 per share upon vesting. These units are scheduled to vest on January 1, 2027, as long as the director continues to serve through that date. After this award, the director beneficially owns 19,181 ordinary shares in total, held directly.
Fabrinet director receives restricted share units as board compensation
A Fabrinet director reported receiving 417 restricted share units of the company’s ordinary shares on December 11, 2025. These units were granted as partial compensation for service on the Board of Directors and carry a grant price of $0, reflecting that they are an incentive award rather than a market purchase.
Each restricted share unit represents a contingent right to receive one ordinary share of Fabrinet stock. The units will vest on January 1, 2027, provided the director continues to serve on the board through that date. Following this grant, the director is reported to beneficially own 510 ordinary shares directly.
Fabrinet director reports equity compensation grant. A Form 4 filing discloses that a director of Fabrinet received 417 restricted share units of the company’s ordinary shares on 12/11/2025 at a stated price of $0, reflecting a compensation award rather than an open-market purchase.
After this grant, the director beneficially owns 18,733 ordinary shares. The filing notes that each restricted share unit represents a contingent right to receive one ordinary share of Fabrinet stock, and the entire award is scheduled to vest on January 1, 2027, provided the director continues to serve on the board through that date.